BioSpace News Archive

Business

Chugai and Lilly Enter into a License Agreement for Oral GLP-1 Agonist, OWL833

The agreement will bolster Lilly’s industry-leading diabetes portfolio

September 26, 2018
·
5 min read
Policy

Cannmart Receives Canada’s First No-Cultivation ACMPR Sales-Only License

Cannmart Inc. (“Cannmart” or “Cannmart.com”) has received its Access to Cannabis for Medical Purposes Regulations (“ACMPR”) medical cannabis “sales-only” license with no cultivation (the “Sales License”), which is the first of its kind to be issued by Health Canada.

September 26, 2018
·
6 min read
Drug Development

Galapagos reports initiation of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in osteoarthritis patients

Galapagos NV (Euronext & NASDAQ: GLPG) reports first dosing in the global ROCCELLA Phase 2 trial with GLPG1972/S201086 in knee osteoarthritis patients.

September 26, 2018
·
5 min read
Business

Helio Training Announces Partnership with Larry H. Miller Sports & Entertainment and the Utah Jazz

Helio Training, an organization specializing in software development training, is pleased to announce a new partnership with Larry H. Miller Sports & Entertainment (LHMSE

September 26, 2018
·
1 min read
BioCapital

National Association of Specialty Pharmacy’s Education Committee Unveils Winners of Abstracts from Members on Boosting Patient Engagement & Enhanced Clinical Outcomes

On the final morning of the sixth annual National Association of Specialty Pharmacy (NASP) meeting, the NASP Education Committee unveiled winners of the submitted abstracts highlighting research in specialty pharmacy, along with efforts to enhance patient engagement and clinical outcomes.

September 26, 2018
·
3 min read
BioForest

Bardy Diagnostics™ Selected as a Winner of the Children’s National Pediatric Medical Device Innovation Competition

Bardy Diagnostics, Inc. announced it was selected as one of six winners of the “Make Your Medical Device Pitch for Kids!” Competition hosted by the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National Health System.

September 26, 2018
·
4 min read
Drug Development

Samsung Bioepis’ Biologics License Application for SB5 Adalimumab Biosimilar Candidate Accepted for Review by the U.S. Food and Drug Administration

The Biologics License Application for SB5 was based on a 52-week Phase 3 study comparing SB5 to the adalimumab reference product

September 26, 2018
·
2 min read
Policy

Charity calls on government to commit 1% of annual cost of dementia to research

Alzheimer’s Research UK, is calling on the UK government to adopt a bold new action plan to bring about a life-changing dementia treatment and improve the lives of people with the condition.

September 26, 2018
·
3 min read
Business

IMMUTEP ENTERS INTO CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT WITH MERCK KGAA, DARMSTADT, GERMANY, AND PFIZER

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”) is pleased to announce that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer.

September 26, 2018
·
9 min read
Deep Vein Thrombosis - A Drug Pipeline Analysis Report by Technavio

Technavio has announced their latest drug pipeline analysis report on deep vein thrombosis. The report includes a comprehensive research on the pipeline molecules under investigation by the pharmaceutical companies within the defined data collection period for the treatment of deep vein thrombosis.

September 26, 2018
·
3 min read